| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $1,109,152 ) |
| 2025 | 2025 | CORNOVUS PHARMACEUTICALS INC. | 261 SAINT RONAN ST | NEW HAVEN | CT | 06511-2313 | SOUTH CENTRAL CT | USA | R42HL156322 | A New Anti-inflammatory Therapy for Ischemic Stroke | 001 | 3 | NIH | 6/12/2025 | $1,109,152 |
| 2025 | 2024 | CORNOVUS PHARMACEUTICALS INC. | 400 FARMINGTON AVE | FARMINGTON | CT | 06032-1913 | CAPITOL | USA | R42HL156322 | A New Anti-inflammatory Therapy for Ischemic Stroke | 000 | 2 | NIH | 10/9/2024 | $0 |
|
 | Issue Date FY: 2024 ( Subtotal = $934,548 ) |
| 2024 | 2024 | CORNOVUS PHARMACEUTICALS INC. | 400 FARMINGTON AVE | FARMINGTON | CT | 06032-1913 | CAPITOL | USA | R42HL156322 | A New Anti-inflammatory Therapy for Ischemic Stroke | 000 | 2 | NIH | 9/12/2024 | $934,548 |
| 2024 | 2021 | CORNOVUS PHARMACEUTICALS INC. | 400 FARMINGTON AVE | FARMINGTON | CT | 06032-1913 | CAPITOL | USA | R44HL152710 | A New Drug Therapy for Advanced Heart Failure | 000 | 2 | NIH | 10/23/2023 | $0 |
| 2024 | 2021 | CORNOVUS PHARMACEUTICALS INC. | 400 FARMINGTON AVE | FARMINGTON | CT | 06032-1913 | CAPITOL | USA | R41HL156322 | A New Anti-inflammatory Therapy for Ischemic Stroke | 000 | 1 | NIH | 11/9/2023 | $0 |
|
 | Issue Date FY: 2021 ( Subtotal = $1,452,200 ) |
| 2021 | 2021 | CORNOVUS PHARMACEUTICALS INC. | 261 SAINT RONAN ST | NEW HAVEN | CT | 06511-2313 | SOUTH CENTRAL CT | USA | R41HL156322 | A New Anti-inflammatory Therapy for Ischemic Stroke | 000 | 1 | NIH | 12/11/2020 | $433,483 |
| 2021 | 2021 | CORNOVUS PHARMACEUTICALS INC. | 261 SAINT RONAN ST | NEW HAVEN | CT | 06511-2313 | SOUTH CENTRAL CT | USA | R44HL152710 | A New Drug Therapy for Advanced Heart Failure | 000 | 2 | NIH | 6/1/2021 | $968,717 |
| 2021 | 2021 | CORNOVUS PHARMACEUTICALS INC. | 261 SAINT RONAN ST | NEW HAVEN | CT | 06511-2313 | SOUTH CENTRAL CT | USA | R44HL152710 | A New Drug Therapy for Advanced Heart Failure | 001 | 2 | NIH | 6/9/2021 | $50,000 |
| 2021 | 2021 | CORNOVUS PHARMACEUTICALS INC. | 261 SAINT RONAN ST | NEW HAVEN | CT | 06511-2313 | SOUTH CENTRAL CT | USA | R44HL152710 | A New Drug Therapy for Advanced Heart Failure | 002 | 2 | NIH | 8/24/2021 | $0 |
|
 | Issue Date FY: 2020 ( Subtotal = $968,717 ) |
| 2020 | 2020 | CORNOVUS PHARMACEUTICALS INC. | 261 SAINT RONAN ST | NEW HAVEN | CT | 06511-2313 | SOUTH CENTRAL CT | USA | R44HL152710 | A New Drug Therapy for Advanced Heart Failure | 000 | 1 | NIH | 7/14/2020 | $968,717 |
|
|